Treatment | Low risk | Intermediate risk | High risk |
---|---|---|---|
Temsirolimus 175/75 mg | |||
n | 14 | 24 | 16 |
Mean (std dev), weeks | 32.4 (22.0) | 21.1 (24.8) | 10.5 (8.8) |
Temsirolimus 175/25 mg | |||
n | 15 | 18 | 21 |
Mean (std dev), weeks | 39.0 (42.3) | 17.6 (11.4) | 11.7 (12.4) |
INV therapy | |||
n | 21 | 21 | 11 |
Mean (std dev), weeks | 8.1 (7.8) | 9.8 (10.3) | 3.3 (2.4) |